Skip to main content
For US Residents Only
  1. What is HSDD?

    That’s the abbreviation for hypoactive sexual desire disorder. It’s a common, treatable medical condition characterized by ongoing low sexual desire that women find frustrating. (“hypoactive” means “low”) If you’re diagnosed with “acquired, generalized” HSDD, it means you haven’t had low sexual desire in the past, but you now have low sexual desire, no matter the […]

  2. What’s Vyleesi?

    Vyleesi (bremelanotide injection) is the first and only FDA-approved as-needed treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). It was approved by the FDA on June 21, 2019. Do not use if you have: high blood pressure that is not controlled (uncontrolled hypertension) known heart (cardiovascular) disease See clinical trials info.

Book Virtual Appointment

with an independent healthcare provider

Book Now